Articles

Stryker, Trevo Retriever, stent thrombectomy, trial, Netherlands

In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a...

Having been active in the age of transformation in which manufacturing, retail, finance, high-tech and oil and gas all experienced in the late 1980s and into the 1990s, I realized that healthcare...

Volcano, Philips, acquisition, FFR, IVUS

The purchase will enable Philips to further expand its advanced imaging capabilities of its angiography suite. Volcano is a leader in intravascular ultrasound (IVUS) and fractional flow reserve (...

Medtronic, Attain Performa, quadripolar leads

Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV) quadripolar leads. Both devices can be...

Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA) scientific assembly and annual meeting....

Doctors at St. Joseph’s Children’s Hospital of Tampa implanted a Melody transcatheter pulmonary valve in a 13-year-old patient in October, marking the 50th time the hospital has given the device...

near-infrared spectroscopy, NIRS, heart attack, stroke, Infraredx, TVC

A study published in the Journal of the American College of Cardiology (JACC) shows intravascular near-infrared spectroscopy (NIRS) can identify lipid core-containing plaques,...

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with...

The U.S. Food and Drug Administration (FDA) today cleared HeartFlow’s FFR-CT (fractional flow reserve—computed tomography) software, which permits non-invasive evaluation of coronary artery blood...

AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab

Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with atrial fibrillation.